Bioinformatic Analysis Of Phosphorylated Proteomes
Bioinformatic analysis of a phosphorylated proteome starts after the search is closed. The table contains protein accessions, residues, localization scores, and, when the samples were quantified, matched intensities. Gene Ontology, KEGG, motif logos, and kinase-enrichment plots annotate the names and flanking sequences in that table. Kinase activity is measured in a separate assay.
Researchers who need the phosphopeptide table can review the MtoZ Biolabs Quantitative Phosphoproteomics Service for titanium dioxide (TiO2) or immobilized metal affinity chromatography (IMAC) enrichment and the site catalog that comes before a pathway map.
What the Site Table Already Contains
Peptide false discovery rate (FDR) and a localization score have already accepted or rejected each row (Beausoleil et al. 2006; Olsen and Mann 2013). MaxQuant, Proteome Discoverer, and FragPipe perform that search. Enrichment software then uses gene symbols and the amino acids around each site. It reads the table, not the spectrum that justified the phosphate.
PhosphoSitePlus records whether a residue has been reported (Hornbeck et al. 2015). A match to that catalog compares the row with earlier literature. Identification in the current sample still comes from the spectrum that passed FDR. Unmodified peptides from the same protein show that the parent sequence was recovered.
The phosphopeptides that passed enrichment and the search are the phosphorylated proteome used below. Pathway terms, motifs, and kinase scores are calculated from lists made out of that table.

Figure 1. Search engines build the phosphosite table. GO, KEGG, motif, and kinase-enrichment tools read names and sequences after that table exists.
Gene Names and Site Motifs
1. Gene Ontology and KEGG
Ten localized sites on one protein and one site on another become two gene identifiers when the table is collapsed to proteins. MAPK, PI3K-Akt, and mTOR appear because those annotations are attached to the gene names (Kanehisa et al. 2017). Summing site intensities to a protein, or keeping only the strongest site, changes which names are tested. The report states which rule was used. Occupancy is calculated from the modified and unmodified forms of the same peptide.
2. Motifs
Motif tools extract amino-acid patterns around localized sites (Schwartz and Gygi 2005). A logo can suggest a kinase class from the flanking sequence. The enzyme that acted in the lysate is tested with an activity, inhibitor, or genetic assay. A motif result is reported with the residues. A KEGG term is reported with the gene names.

Figure 2. GO and KEGG score collapsed protein names. Motif tools use flanking sequences. The two results answer different questions.
Kinase Catalogs and Network Maps
Kinase Enrichment Analysis, iGPS, NetworKIN, and kinase-substrate enrichment analysis (KSEA) score a site list against published kinase–substrate pairs or motifs (Linding et al. 2007; Casado et al. 2013). The score shows that a published set is enriched in the list. An activity, inhibitor, or genetic assay tests whether that kinase acted in the sample.
Kinase activity profiling is described on the MtoZ Biolabs Kinome Profiling Service page.
STRING and Cytoscape draw protein–protein associations among the detected names (Szklarczyk et al. 2023). A hub is a count of those associations. Time-series clustering groups phosphopeptides that were quantified at the sampled times.
Residue-level identification of one site is described on the MtoZ Biolabs Phosphorylation Site Identification Service page.
How to Read the Annotation
Result |
Source |
Next measurement, when that is the question |
|---|---|---|
Gene names detected from phosphopeptides |
Accessions of accepted phosphopeptides |
A pathway activity assay |
A residue also listed in PhosphoSitePlus |
A literature catalog |
The spectrum from this run |
A flanking sequence resembles a kinase motif |
Motif extraction on localized sites |
An activity or inhibitor assay |
A kinase class is enriched |
KSEA, NetworKIN, or a related catalog |
Kinase activity |
Proteins share a KEGG term |
A collapsed gene list |
A pathway-output assay |
Names form a connected group |
STRING or Cytoscape |
A direct-interaction assay |
A phosphopeptide rose at a sampled time |
Intensities at the harvested times |
Only the times that were collected |
Many phosphopeptides are missing |
Peptides not captured or not sampled |
Another capture, or a targeted rerun |
Differential testing compares matched phosphopeptide intensities with a t-test, ANOVA, or a related model. Batch correction normalizes those same columns. A heatmap displays the intensities that were tested.
What to Report with the Figure
State whether sites were summed to proteins or kept as residues, which localization cutoff defined the motif window, and which kinase catalog was used. Differential testing uses the intensity columns. Gene Ontology, KEGG, motifs, networks, and kinase catalogs annotate names or published pairs. If missing phosphopeptides are imputed, the report names the model. Otherwise those cells stay empty.
Biological replicates are the samples behind a difference that will be used in an enrichment test. Searching one file again with a looser localization cutoff does not add biological samples. A diagnostic cutoff or a therapeutic-target decision uses a validated assay.

Figure 3. Motif scores and kinase-catalog scores are annotations of a finished site table. Kinase activity, a network hub, and pathway output use other measurements.
Frequently Asked Questions
1. Is searching the raw file part of phosphorylated-proteome bioinformatics?
The search builds the site table. Annotation starts after peptide FDR and localization have been applied.
2. Does a KEGG MAPK term mean the pathway was activated?
It means detected names carry that annotation. Pathway activity is measured with a readout of the cascade.
3. Can KSEA replace a kinase activity assay?
KSEA tests a published substrate list. Activity is measured with an enzyme, inhibitor, or genetic assay.
4. Should phosphosites be collapsed to proteins before enrichment?
Collapse them when the figure is about protein names, and state the rule. Site results stay on localized residues.
5. Can missing phosphopeptides be filled in before clustering?
Missing values usually mean the peptide was not captured or not sampled. Any imputed value is reported with the model that produced it.
MtoZ Biolabs can provide phosphoproteomics from phosphate-selective enrichment through LC-MS/MS site tables, and can add Gene Ontology, motif, or kinase-catalog annotation after those tables are finalized. The report states the protein-collapse rule and the catalog that was used.
If a site-to-protein mapping or a kinase-enrichment figure needs to be planned, project details can be submitted for a feasibility review.
Reference
- S.A. Beausoleil, J. Villen, S.A. Gerber, J. Rush, S.P. Gygi (2006). A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol., 24, 1285-1292. https://doi.org/10.1038/nbt1240
- J.V. Olsen, M. Mann (2013). Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteomics, 12, 3444-3452. https://doi.org/10.1074/mcp.O113.034181
- P.V. Hornbeck, B. Zhang, B. Murray, J.M. Kornhauser, V. Latham, E. Skrzypek (2015). PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res., 43, D512-D520. https://doi.org/10.1093/nar/gku1267
- D. Schwartz, S.P. Gygi (2005). An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol., 23, 1391-1398. https://doi.org/10.1038/nbt1146
- R. Linding, L.J. Jensen, G.J. Ostheimer, M.A. van Vugt, C. Jorgensen, I.M. Miron, et al. (2007). Systematic discovery of in vivo phosphorylation networks. Cell, 129, 1415-1426. https://doi.org/10.1016/j.cell.2007.05.052
- P. Casado, J.C. Rodriguez-Prados, S.C. Cosulich, S. Guichard, B. Vanhaesebroeck, S. Joel, P.R. Cutillas (2013). Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal., 6, rs6. https://doi.org/10.1126/scisignal.2003573
- M. Kanehisa, M. Furumichi, M. Tanabe, Y. Sato, K. Morishima (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res., 45, D353-D361. https://doi.org/10.1093/nar/gkw1092
- D. Szklarczyk, R. Kirsch, M. Koutrouli, K. Nastou, F. Mehryary, R. Hachilif, et al. (2023). The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res., 51, D638-D646. https://doi.org/10.1093/nar/gkac1000